Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Natl Compr Canc Netw ; 17(12): 1459-1462, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31805529

RESUMO

Inflammatory myofibroblastic tumor (IMT), a rare sarcoma, is primarily treated via resection of the mass. However, there is no standard treatment for recurrence or unresectable tumors. Almost 50% of IMTs carry ALK gene rearrangement that can be treated using ALK inhibitors, but therapeutic options for ALK-negative tumors are limited. This report describes a woman aged 22 years with unresectable ALK-negative IMT. Next-generation sequencing revealed a TFG-ROS1 fusion, and she had a partial response to the ROS1 inhibitor ceritinib. This report provides the first published demonstration of a patient with IMT with ROS1 fusion successfully treated using ceritinib. Our study suggests that targeting ROS1 fusions using the small molecule inhibitor shows promise as an effective therapy in patients with IMT carrying this genetic alteration, but this requires further investigation in large clinical trials.


Assuntos
Neoplasias Abdominais/tratamento farmacológico , Miosite/tratamento farmacológico , Neoplasias de Tecido Muscular/tratamento farmacológico , Proteínas de Fusão Oncogênica/genética , Proteínas Tirosina Quinases/genética , Proteínas/genética , Proteínas Proto-Oncogênicas/genética , Pirimidinas/uso terapêutico , Sulfonas/uso terapêutico , Neoplasias Abdominais/genética , Neoplasias Abdominais/patologia , Adulto , Feminino , Humanos , Miosite/genética , Miosite/patologia , Neoplasias de Tecido Muscular/genética , Neoplasias de Tecido Muscular/patologia , Proteínas de Fusão Oncogênica/antagonistas & inibidores , Prognóstico , Inibidores de Proteínas Quinases/uso terapêutico , Proteínas Tirosina Quinases/antagonistas & inibidores , Proteínas/antagonistas & inibidores , Proteínas Proto-Oncogênicas/antagonistas & inibidores , Adulto Jovem
2.
Drug Des Devel Ther ; 18: 1459-1467, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38707613

RESUMO

Background: Ondansetron reduces the median effective dose (ED50) of prophylactic phenylephrine to prevent spinal-induced hypotension (SIH) during cesarean delivery. However, the exact dose response of phenylephrine in combination with prophylactic ondansetron for preventing SIH is unknown. Therefore, this study aimed to determine the dose-response of phenylephrine to prevent SIH in cesarean delivery when 4 mg of ondansetron was used as a preventive method. Methods: A total of 80 parturients were enrolled and divided randomly into four groups (n = 20 in each group) who received either 0.2, 0.3, 0.4, or 0.5 µg/kg/min of prophylactic phenylephrine. Ten minutes before the initiation of spinal induction, 4 mg prophylactic ondansetron was administered. The effective dose of prophylactic phenylephrine was defined as the dose required to prevent hypotension after the period of intrathecal injection and up to neonatal delivery. The ED50 and ED90 of prophylactic phenylephrine and 95% confidence intervals (95% CI) were calculated using probit analysis. Results: The ED50 and ED90 for prophylactic phenylephrine to prevent SIH were 0.25 (95% CI, 0.15 to 0.30), and 0.45 (95% CI, 0.39 to 0.59) µg/kg/min, respectively. No significant differences were observed in the side effects and neonatal outcomes between the four groups. Conclusion: The administration of 4 mg of prophylactic ondansetron was associated with an ED50 of 0.25 (95% CI, 0.15~0.30) and ED90 of 0.45 (95% CI, 0.39~0.59) µg/kg/min for phenylephrine to prevent SIH.


Assuntos
Raquianestesia , Cesárea , Relação Dose-Resposta a Droga , Hipotensão , Ondansetron , Fenilefrina , Adulto , Feminino , Humanos , Gravidez , Anestesia Epidural , Raquianestesia/efeitos adversos , Hipotensão/prevenção & controle , Hipotensão/induzido quimicamente , Ondansetron/administração & dosagem , Fenilefrina/administração & dosagem
3.
Zhongguo Zhong Yao Za Zhi ; 38(19): 3332-7, 2013 Oct.
Artigo em Zh | MEDLINE | ID: mdl-24422403

RESUMO

OBJECTIVE: To observe the effect of ginseng polysaccharide (GPS) on the proliferation and apoptosis of human nasopharyngeal cancer cells CNE-2, and discuss the possible mechanism. METHOD: The effect of GPS on the growth of CNE-2 cells was observed by CCK8 assay. CNE-2 cells in the logarithmic phase were collected and processed respectively with different concentrations (0, 0. 1, 0. 2, 0. 3. 0. 4 g L-1) of GPS for 48 h. The flow cytometry was used to detect its induction effect on CNE-2 cell apoptosis. Hoechst-33258 cell staining and electron microscope were used to observe the morphological changes of cells. The beta-catenin mRNA expression was detected by Real-time PCR. The protein localizations and expressions of beta-catenin and TCF4 were tested by the immunofluorescence staining. The expressions of beta-catenin, Bcl-2 and Bax proteins were detected by Western blot. RESULT: CCK8 assay results showed that GPS could remarkably inhibit the proliferation of CNE-2 cells, with dose-time dependence. IC50 of cells induced with GPS for 48 h was 0. 39 g L-1. After being processed with GPS with concentrations of 0.1, 0. 2, 0. 3, 0. 4 g L-1 for 48 h, the cell apoptosis rates of human nasopharyngeal cancer cells CNE-2 were (5. 69 +/- 0. 29)% , (10. 3 +/- 0. 63)% , (15. 4 +/- 0. 74 ) % and (35. 7 +/- 1. 86)% , respectively. Significant difference was observed compared with the control group (2. 08 +/- 0. 11) % (P <0. 05). The results of Hoechst-33258 staining showed the characteristics of cell apoptosis. Under the electron microscope, apoptosis bodies could be observed among CNE-2 cells induced with GPS with the concentration of 0. 4 g L -1 for 48 h. The results of Real-time PCR showed a significant reduction in beta-catenin mRNA expression. The results of laser confocal microscopy revealed notable decrease of beta-catenin and TCF4 expression in nucleus and transfer from nucleus to cell membranes in beta-catenin expression areas after being processed with GPS for 48 h. Western blot showed significant decrease in the expressions of beta-catenin and anti-apoptosis protein Bcl-2, with an increasing expression in apoptosis-promoting protein Bax (P <0. 05). CONCLUSION: GPS could significantly inhibit the proliferation of CNE-2 cells and promote thier apoptosis. The obstruction of Wnt/beta-catenin signaling pathway may be an important mechanism for GPS to induce the apoptosis of human nasopharyngeal cancer cells CNE-2.


Assuntos
Apoptose/efeitos dos fármacos , Neoplasias Nasofaríngeas/metabolismo , Panax/química , Polissacarídeos/farmacologia , Apoptose/genética , Carcinoma , Linhagem Celular Tumoral , Citometria de Fluxo , Humanos , Carcinoma Nasofaríngeo , Reação em Cadeia da Polimerase em Tempo Real , Via de Sinalização Wnt/efeitos dos fármacos , beta Catenina/genética
4.
J Hazard Mater ; 427: 128169, 2022 Apr 05.
Artigo em Inglês | MEDLINE | ID: mdl-34979386

RESUMO

Traditionally, lead (Pb) in rice grains has been thought to be mostly derived from soil, and the contribution of aerosol Pb remains so far unknown. Based on a meta-analysis, we surprisingly found rice Pb content decreased proportionally with urban atmospheric Pb concentrations in major rice-growing provinces in China during 2001-2015, suggestive of the strong influence of long-range Pb transport on agricultural environment. With the combination of field survey, field experiment, as well as a predictive model, we confirmed high contribution of atmospheric exposure to rice grain Pb in China. We for the first time developed a predictive mathematical model which revealed that aerosol Pb accumulation ratios of rice grains were related to both grain weight and accumulation types. We successfully predicted the national-scale rice Pb in China on the basis of the public data of urban PM2.5 from 19 rice-growing provinces and proposed a seasonal atmospheric Pb limit of 0.20 µg m-3 based on the safe threshold level of Pb in rice, which was much lower than the current limit of 1 µg m-3 set in China.


Assuntos
Oryza , Poluentes do Solo , China , Grão Comestível/química , Chumbo , Solo , Poluentes do Solo/análise
5.
Front Pharmacol ; 12: 608198, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34054513

RESUMO

Purpose: Prophylactic infusion of a vasopressor is preferred as a rational choice in clinical practice in Cesarean delivery. Metaraminol is one of most common vasopressors used in obstetric clinical practice. However, the dose-response of metaraminol has not been fully determined and the optimal infusion dose is unknown. Therefore, this study aimed to determine the median effective dose (ED50) and 90% effective dose (ED90) of weight-based fixed-rate metaraminol infusions for preventing spinal-anesthesia-induced hypotension in patients having combined spinal-epidural anesthesia for elective Caesarean delivery. Methods: One hundred and seventeen patients with singleton pregnancies were enrolled and randomly allocated into one of five groups in this study. Patients received prophylactic metaraminol infusion at a fixed rate of 0, 0.25, 1.0, 1.75 or 2.5 µg/kg/min in each group immediately after induction with intrathecal 10 mg of hyperbaric bupivacaine mixed with 5 µg of sufentanil. An effective prophylactic dose was defined as no occurrence of hypotension during the period of spinal introduction and neonatal delivery. Values for ED50 and ED90 of prophylactic infusion of metaraminol were calculated using probit regression. Characteristics of spinal anesthesia and side effects were recorded. Results: The ED50 and ED90 values of weight-based fixed rate of metaraminol infusion were 0.64 (95% CI, 0.04-1.00) µg/kg/min and 2.00 (95% CI, 1.58-2.95) µg/kg/min respectively. The incidence of hypotension decreased with an increased infusion rate of metaraminol in the five groups (test for trend, p < 0.001). The incidence of hypotension was similar between group 0 and 0.25, but significant higher than other groups; the incidence of hypotension was also similar between group 1.0 and 1.75, but higher than group 2.5. The incidence of reactive hypertension was significantly higher in group 2.5 compared to the other groups. Physician interventions were more frequent in group 0, 0.25 and 2.5 than in group 1.0 and 1.75 (adjusted p < 0.001). No difference was found in neonatal outcomes, including Apgar score and pH value of the umbilical artery. Conclusion: In summary, we have compared four different prophylactic weight-based infusion doses of metaraminol for preventing post-spinal hypotension in Cesarean delivery. The ED50 and ED90 values of metaraminol infusion for preventing spinal anesthesia-induced hypotension were 0.64 µg/kg/min and 2.00 µg/kg/min, respectively. This finding may be helpful for guiding clinical practice and further research.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA